Costs and clinical outcomes associated with use of ranolazine for treatment of angina.
about
Update on ranolazine in the management of angina.Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study.Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina.Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.A novel multi-unit tablet for treating circadian rhythm diseases.Ranolazine enhances the antiarrhythmic activity of amiodarone by accelerating conversion of new-onset atrial fibrillation after cardiac surgery.
P2860
Costs and clinical outcomes associated with use of ranolazine for treatment of angina.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Costs and clinical outcomes associated with use of ranolazine for treatment of angina.
@en
type
label
Costs and clinical outcomes associated with use of ranolazine for treatment of angina.
@en
prefLabel
Costs and clinical outcomes associated with use of ranolazine for treatment of angina.
@en
P2093
P1476
Costs and clinical outcomes associated with use of ranolazine for treatment of angina.
@en
P2093
Charles E Phelps
Erin K Buysman
Gabriel Gomez Rey
P304
1395-1407.e4
P356
10.1016/J.CLINTHERA.2012.04.025
P577
2012-05-16T00:00:00Z